Homöopathische Prüfsymptome unter Placebo?

Zusammenfassung

Immer wieder wurde in placebokontrollierten homöopathischen Arzneimittelprüfungen beobachtet, dass Prüfsymptome auch bei Probanden unter Placebo auftraten. Was bedeutet dieses Phänomen für die Homöopathie? Hierzu werden mehrere Hypothesen vorgestellt und diskutiert.

Summary

In placebo-controlled homeopathic provings it was repeatedly observed that proving symptoms also occurred in subjects receiving placebo. What does this phenomenon imply for the understanding of homeopathy? Several hypotheses are presented and discussed.

Schlüsselwörter

Arzneimittelprüfung - Placebo - Verumsymptome unter Placebo

Keynodes

Proving - placebo - verum symptoms under placebo

• Literatur

• 1 Amanzio M, Corazzini LL, Vase L, Benedetti F. A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain 2009; 146: 261-269
• 2 Bayr G. A model for homeopathic drug tests including statistical analysis. Br Homeopath J 1986; 75: 80-88
• 3 Boericke W. Homöopathische Mittel und ihre Wirkungen. 9. Aufl. Leer: Grundlagen und Praxis; 2008
• 4 Dantas F et al A systematic review of the quality of homeopathic trials published from 1945 to 1995. Homeopathy 2007; 96: 4-16
• 5 Dantas F et al Author’s response: we must distunguish symptoms caused by the medicine from other symptoms. Homeopathy 2007; 96: 275-276
• 6 Hahnemann S. Organon der Heilkunst. Textkritische Ausgabe. Hrsg. J. M. Schmidt Stuttgart: Haug; 1999
• 7 Häuser W, Bartram C, Bartram-Wunn E, Tölle T. Adverse events attributable to nocebo in randomised controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: a systematic review. Clin J Pain 2012; 28: 437-451
• 8 Häuser W et al Nocebophänomene in der Medizin: Bedeutung im klinischen Alltag. Dtsch Arztebl Int 2012; 109(26): 459-465
• 9 Kunst M. Okoubaka, ein neues homöopathisches Arzneimittel. AHZ 1972; 3: 116-121
• 10 Lucae C, Wischner M. Rein oder nicht rein?. ZKH 2010; 54(1): 13-22
• 11 Möllinger H et al Homeopathic pathogenetic trials produce specific symptoms different from placebo. Forschende Komplementmed 2009; 16: 105-110
• 12 Mora MS, Nestoriuc Y, Rief W. Lessons learned from placebo groups in antidepressant trials. Philos Trans R Soc Lond B Biol Sci 2011; 366: 1879-1888
• 13 Riley DS. Materia Medica of New and Old Homeopathic Medicines. Berlin: Springer; 2012
• 14 Schlüren E. Okoubaka aubrevillei − ein klinischer Erfahrungsbericht. AHZ 1991; 236: 225-231
• 15 Sherr J. Dynamics and Methodology of Homeopathic Provings. London: Dynamis School; 1994
• 16 Sherr J, Quirk T. Systematic review of homeopathic pathogenetic trials: an exzess of rigour?. Homeopathy 2007; 96: 273-275
• 17 Signorini et al Classical and new proving methodology: Provings of plumbum metallicum and piper methysticum and comparison with a classical proving of plumbum metallicum. Homeopathy 2005; 94: 164-174
• 18 Signorini A. Guest editorial. Finnally some light on the ,Pillar of Homeopathy‘. Homeopathy 2007; 96: 1-2
• 19 Teut M, Dahler J, Hirschberg U et al Homeopathic drug proving of Okoubaka aubrevillei: a randomised placebo-controlled trial. Trials 2013; 14(1): 96 [open access]
• 20 Wagner H, Kreutzkamp B, Jurcic K. Inhaltsstoffe und Pharmakologie der Okoubaka aubrevillei-Rinde. Planta Med 1985; 5: 404-407
• 21 Walach H, Kösters H, Henning T, Haag G. The effects of homeopathic belladonna 30 CH in healthy volunteers − a randomised, double blind experiment. J Psychosom Res 2001; 50: 155-160
• 22 Walach H. Entanglement model of homeopathy as an example of generalized entanglement predicted by weak quantum theory. Forsch Komplementärmed Klass Naturheilkd 2003; 10: 192-200
• 23 Walach H, Sherr J, Schneider R et al Homeopathic proving symptoms: result of a local, non-local, or placebo-process? A blinded, placebo-controlled pilot study. Homeopathy 2004; 93: 179-185
• 24 Walach H. Generalized entanglement: a new theoretical model for understanding the effects of complementary and alternative medicine. J Altern Complement Med 2005; 11(3): 549-559
• 25 Walach H. Homeopathic pathogenetic trials produce more specific than non- specific symptoms: results from two double-blind placebo controlled trials. J Psychopharm 2008; 22(5): 543-552
• 26 Walach H. Homeopathic pathogenetic trials: A summary of 20 years of reflection, data collection, and analysis. In: Witt C, Albrecht H, eds New Directions in Homeopathy Research. Essen: KVC; 2009